Results 151 to 160 of about 3,464 (299)

Exploring and enhancing community awareness on antimicrobial resistance: perspectives from world antimicrobial resistance awareness week celebration in Ghana. [PDF]

BMC Public Health
Loglo AD, Nkrumah-Appau M, Deke J, Asiamah CK, Antwi PB, Newton S, Kotochi S, Nyame MK, Oppong M, Adu CAT, Dorkenoo RM, Sogbo V, Boadi AO, Ayinlooya NEA, Manu S, Amoah B, Ankomah J, Quartey MK, Bansah SE, Essel W, May J, Dekker D, Berg S, Khan N, Akenten CW.   +24 more
europepmc   +1 more source

Brinkerhoff - Henry M. Brinkerhoff (ca. 1870)

, 2007
A.B.; valedictorian; Phi Gamma Delta; Philomathaean; orator, anniversary, 1869; Fourth honor; entered Freshman, 1865. Prepared in Academy at his home, Hunterstown, Adams county, Pa. LL.B., Law School, Albany, N.Y., 1873. Born Sept.
Tipton & Myers, Gettysburg, PA
core  

Loss of proton‐sensing TDAG8 increases tumor progression in mouse models of colon cancer

Molecular Oncology, EarlyView.
Loss of the pH‐sensing receptor TDAG8 accelerates colorectal cancer progression in mice. Animals lacking TDAG8 expression had increased tumor growth, DNA damage, and recruitment of tumor‐associated immune cells, including macrophages, neutrophils, and monocytes.
Ermanno Malagola, Yasmine Illi, Anna Bircher, Marijn Wilmink, Rachele F. Malagutti, Solenn Ottié, Cordelia Schuler, Pedro A. Ruiz, Cheryl de Vallière, Klaus Seuwen, Gerhard Rogler, Martin Hausmann   +11 more
wiley   +1 more source

Extreme Temperatures, Hospital Utilization and Public Health Insurance Spending. [PDF]

Int J Public Health
Kim Y, Miao Q, Zhu L.
europepmc   +1 more source

PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model

Molecular Oncology, EarlyView.
Breast cancer remains a major cause of cancer death in women, frequently developing endocrine therapy resistance. This study demonstrates that upregulated p21‐activated kinase 1 (PAK1) activity drives resistance to tamoxifen and long‐term estrogen deprivation in ER+ breast cancer models.
Luisa Schwarzmüller, Janina Müller, Efstathios‐Iason Vlachavas, Lukas Beumers, Lena Fleischhacker, Sara Burmester, Angelika Wörner, Sabine Karolus, Dominic Helm, Cindy Körner, Stefan Wiemann   +10 more
wiley   +1 more source

Impact of a CKD Population Health Intervention on Healthcare Utilization and Costs. [PDF]

Clin J Am Soc Nephrol
Danda V, Tummalapalli SL.
europepmc   +1 more source

[Photograph 2012.201.B0328.0286]

, 1947
Photograph used for a story in the Daily Oklahoman newspaper. Caption: "Mott M. Keys, an actuary for the state insurance board who retired in January with a total of 32 years service in state government, died Thursday at Mercy Hospital.
Meek, Richard B.
core  

Spatial and single‐nuclei transcriptomics reveals idiosyncratic and generic patterns in papillary and anaplastic thyroid cancers

Molecular Oncology, EarlyView.
Matched spatial transcriptomics and single‐nuclei RNA‐seq were generated for anaplastic and BRAFV600E papillary thyroid cancers revealing generic and tumor‐specific states occurring in cancer cells and in the tumor microenvironment. In this context, cancer dedifferentiation mirrored organoid maturation through ordered thyroid marker gain/loss ...
Adrien Tourneur, Joel Rodrigues Vitória, Manuel Saiselet, Ligia Craciun, Denis Larsimont, Anne Lefort, Frédérick Libert, Carine Maenhaut, Sabine Costagliola, Maxime Tarabichi, Mirian Romitti, Vincent Detours   +11 more
wiley   +1 more source

Benefits of an anti-inflammatory diet compared to a low-residue diet during concurrent chemoradiation therapy for patients with locally advanced cervical cancer: a randomized clinical trial. [PDF]

Front Nutr
Luvián-Morales J, Rueda-Escalona AA, Delgadillo-González M, Cetina-Pérez LDC, Villalpando-Sánchez DC, Gómez-Jiménez AM, Rodríguez-Moreno MI, Medina-Contreras O, Castro-Eguiluz D.   +8 more
europepmc   +1 more source

Inhibition of cyclin‐dependent kinases 12/13 using CT7439 as a treatment for colorectal cancer with CDK12 upregulation

Molecular Oncology, EarlyView.
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington, Divya L. Dayanidhi, Mohammad Zokaasadi, John B. Mantyh, Pelumi D. Olawuni, Gabrielle Rupprecht, Jeremy M. Force, Shannon McCall, Ashwani K. Bahl, David S. Hsu, Jason A. Somarelli   +10 more
wiley   +1 more source